Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -18.08% vs -35.82% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -8.97% vs -462.89% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -36.68% vs -398.43% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 5.56% vs -5.26% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Zhejiang Wecome Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -18.08% vs -35.82% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -50.34% vs -36.07% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -8.97% vs -462.89% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -297.02% vs 469.81% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -36.68% vs -398.43% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -31.81% vs -223.58% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 5.56% vs -5.26% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 90.00% vs -52.38% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






